Search company, investor...

MK biotech

mkbiotech.co.kr

Founded Year

2017

Stage

Series A | Alive

Total Raised

$6.78M

Valuation

$0000 

Last Raised

$4.91M | 3 yrs ago

About MK biotech

MK biotech is an animal biotechnology company that researches and develops animal cloning, embryo transfer, and stem cell technology.

Headquarters Location

282-10, Munji-ro, Yuseong-gu Rm 201

Daejeon, 34050,

South Korea

Missing: MK biotech's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: MK biotech's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing MK biotech

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

MK biotech is included in 1 Expert Collection, including Regenerative Medicine.

R

Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

MK biotech Patents

MK biotech has filed 1 patent.

The 3 most popular patent topics include:

  • Biotechnology
  • Cloning
  • Cryobiology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/18/2019

Developmental biology, Biotechnology, Cryobiology, Genetics, Cloning

Application

Application Date

7/18/2019

Grant Date

Title

Related Topics

Developmental biology, Biotechnology, Cryobiology, Genetics, Cloning

Status

Application

MK biotech Frequently Asked Questions (FAQ)

  • When was MK biotech founded?

    MK biotech was founded in 2017.

  • Where is MK biotech's headquarters?

    MK biotech's headquarters is located at 282-10, Munji-ro, Yuseong-gu, Daejeon.

  • What is MK biotech's latest funding round?

    MK biotech's latest funding round is Series A.

  • How much did MK biotech raise?

    MK biotech raised a total of $6.78M.

  • Who are the investors of MK biotech?

    Investors of MK biotech include POSCO Capital, NAU IB Capital, DS Asset Management, Donghoon Investment and K-Run Ventures.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.